![Mark de Rosch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark de Rosch
Conseiller Juridique Général chez
CERVOMED INC.
Fortune : - $ au 31/07/2026
Profil
Dr. Mark de Rosch is an Executive VP-Regulatory & Government Affairs at CervoMed, Inc. Dr. de Rosch was previously employed as a Chief Operating Officer by Aura Biosciences, Inc., a Chief Regulatory Officer by Epizyme, Inc., a Senior VP-Regulatory Affairs & Quality Assurance by Nightstar Therapeutics Ltd., a Vice President-Regulatory Affairs by Akebia Therapeutics, Inc., a Vice President-Regulatory Affairs by The Christmas Consortium, LLC, a Senior Director-Global Regulatory Strategy by Vertex Pharmaceuticals, Inc., a Director-Regulatory Affairs by Berlex Laboratories, Inc., a Research Chemist by Diatide, Inc., a Research Chemist by Mallinckrodt Medical, Inc., and a VP-Regulatory Drugs & US Operations by Voisin Consulting, Inc. He received his undergraduate degree from the University of Wisconsin Parkside, a graduate degree from the University of California San Diego and a doctorate degree from the University of California San Diego.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CERVOMED INC. -.--% | 11/02/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de Mark de Rosch
| Sociétés | Poste | Début |
|---|---|---|
| CERVOMED INC. | Conseiller Juridique Général | 13/11/2024 |
Anciens postes connus de Mark de Rosch
| Sociétés | Poste | Fin |
|---|---|---|
| AURA BIOSCIENCES, INC. | Directeur des opérations | 30/05/2023 |
| EPIZYME, INC. | Conseiller Juridique Général | 01/03/2021 |
| NIGHTSTAR THERAPEUTICS PLC | Conseiller Juridique Général | 01/09/2019 |
| AKEBIA THERAPEUTICS, INC. | Conseiller Juridique Général | 01/02/2018 |
Inspiration Biopharmaceuticals, Inc.
 Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Produces intravenous recombinant therapies and develops non-invasive applications | Conseiller Juridique Général | 01/05/2013 |
Formation de Mark de Rosch
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Produces intravenous recombinant therapies and develops non-invasive applications | Health Technology |
Aura Biosciences, Inc.
 Aura Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company leveraging novel targeted oncology platform to develop new standard of care across multiple cancer indications | Health Technology |
Mallinckrodt Medical, Inc.
 Mallinckrodt Medical, Inc. Medical SpecialtiesHealth Technology Manufactures and markets healthcare products | Health Technology |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Akebia Therapeutics, Inc.
 Akebia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs for kidney diseases | Health Technology |
Diatide, Inc.
 Diatide, Inc. Pharmaceuticals: GenericHealth Technology Diatide, Inc. is a company based in Londonderry, NH. Diatide, Inc. was founded by André L. Lamotte. | Health Technology |
Epizyme, Inc.
 Epizyme, Inc. BiotechnologyHealth Technology Develops therapeutics for the treatment of patients with genetically defined cancers | Health Technology |
Berlex Laboratories, Inc. | Health Technology |
University of Wisconsin Parkside
 University of Wisconsin Parkside Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voisin Consulting, Inc.
 Voisin Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides product development consulting services | Commercial Services |
Nightstar Therapeutics Ltd.
 Nightstar Therapeutics Ltd. BiotechnologyHealth Technology Operates as a gene therapy company that develops novel treatments for patients suffering from inherited retinal diseases | Health Technology |
CervoMed, Inc.
 CervoMed, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops novel therapies | Commercial Services |
